Physician
Rheumatology
Dr. James R. Odell, MD
|
|
Give Review
James Odell is an expert in the field of Rheumatology. He researched medicine at University of Nebraska Medical Center. University of Nebraska Medical Center is a one of the best medicals schools. University of Nebraska Medical Center has a rank of 60 in research and a 4 in primary care He received 1 awards: "CMS Meaningful Use Stage 1 Certification". James Odell is a published MD. He published 86 publications, including: 'Anticytokine therapy--a new era in the treatment of rheumatoid arthritis?'
Publications
- Rheumatoid Arthritis consensus conference; July 22-23, 2010: Clinical trial priorities and trial design issues.
- To improve outcomes we must define and measure them: toward defining remission in rheumatoid Arthritis.
- AJC editor's consensus: rheumatoid Arthritis and atherosclerotic cardiovascular disease.
- Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid Arthritis.
- Shoulder arthroplasties have fewer complications than hip or Knee arthroplasties in US veterans.
- Physician preference: filling the evidence gap.
- Minocycline-induced hyperpigmentation in rheumatoid Arthritis.
- It is the best of times; it is the worst of times: is there a way forward? A plethora of treatment options for rheumatoid Arthritis, but critical trial design issues.
- The BeSt way to treat early rheumatoid Arthritis?
- The horseless carriage: moving forward with the hybrid ACR.
- Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid Arthritis.
- Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoArthritis.
- Treatment of early seropositive rheumatoid Arthritis: doxycycline plus methotrexate versus methotrexate alone.
- Therapeutic strategies for rheumatoid Arthritis.
- Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid Arthritis?
- Glucocorticoids and rheumatoid Arthritis: back to the future?
- Treatment of rheumatoid Arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two...
- Treating rheumatoid Arthritis early: a window of opportunity?
- Chondrex: new marker of joint Disease.
- Effects of disease management programs on functional status of patients with rheumatoid Arthritis.
- Making an impact on mortality in rheumatoid Arthritis: targeting cardiovascular comorbidity.
- Reporting disease activity in clinical trials of patients with rheumatoid Arthritis: EULAR/ACR collaborative recommendations.
- Rheumatoid Arthritis initial therapy: unanswered questions.
- Evaluation and documentation of rheumatoid Arthritis disease status in the clinic: which variables best predict change in therapy.
- Characterization of thyroglobulin-directed and polyreactive catalytic antibodies in autoimmune Disease.
- A prospective approach to investigating the natural history of preclinical rheumatoid Arthritis (RA) using first-degree relatives of probands with RA.
- Conventional DMARD options for patients with a suboptimal response to methotrexate.
- The changing face of rheumatoid Arthritis therapy: results of serial surveys.
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid Arthritis.
- Plasma 25,OH vitamin D concentrations are not associated with rheumatoid Arthritis (RA)-related autoantibodies in individuals at elevated risk for RA.
- Evaluating severity and status in rheumatoid Arthritis.
- Consensus recommendations for the assessment and treatment of rheumatoid Arthritis.
- Combinations of conventional Disease-modifying antirheumatic drugs.
- TNF-alpha inhibition: the need for a tumor necrosis factor thermostat.
- How is it best to treat early rheumatoid Arthritis patients?
- Rheumatoid Arthritis: the crisis in clinical research.
- Rheumatoid Arthritis: new developments in the use of existing therapies.
- Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.
- Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid Arthritis: a preventive strategy.
- Treatment of early seropositive rheumatoid Arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial.
- Combination therapy in rheumatoid Arthritis: a comment.
- Is there a role for antibiotics in the treatment of patients with rheumatoid Arthritis?
- Anticytokine therapy--a new era in the treatment of rheumatoid Arthritis?
- Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid Arthritis.
- HLA-DRB1 typing in rheumatoid Arthritis: predicting response to specific treatments.
- The therapeutic pyramid: a work in progress.
- Treatment of early rheumatoid Arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial.
- Combination DMARD therapy for rheumatoid Arthritis: a step closer to the goal.
- Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
- Treatment of rheumatoid Arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
- Effects of muscle-strength training on the functional status of patients with osteoArthritis of the knee joint.
- The treatment of osteoArthritis of the knee with pulsed electrical stimulation.
- The use of outcome measures to evaluate clinical rheumatology curriculum changes.
- Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid Arthritis.
- Anterior tibial mass: an unusual complication of popliteal cysts.
- Gout in Heberden's nodes.
- The spectrum of Epstein-Barr virus Disease.
- Tubulointerstitial renal Disease in systemic lupus erythematosus.
- Weekly pulse methotrexate in rheumatoid Arthritis. Clinical and immunologic effects in a randomized, double-blind study.
- Systemic lupus erythematosus without clinical renal abnormalities: renal biopsy findings and clinical course.
- In vitro production of anti-histone antibodies by spleen Cells from young autoantibody negative NZB/NZW mice.
- Centrilobular hepatic fibrosis following acetaminophen-induced hepatic necrosis in an alcoholic.
- Thromboangiitis obliterans (Buerger's Disease) and smokeless tobacco.
- Improved survival in murine lupus as the result of selenium supplementation.
- In vitro anti-histone antibody production by peripheral blood Cells from patients with systemic lupus erythematosus.
- Lack of clinical benefit after treatment of systemic sclerosis with total lymphoid irradiation.
- Selenium and the immune response: 2. Enhancement of murine cytotoxic T-lymphocyte and natural killer Cell cytotoxicity in vivo.
- Serum selenium concentrations in rheumatoid Arthritis.
- Pharmacotherapy: concepts of pathogenesis and emerging treatments. Novel therapeutics - exciting gifts but how best to use them?
- Treatment of early seropositive rheumatoid Arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine.
- Treatment of relapse after autologous blood stem cell transplantation for severe rheumatoid Arthritis.
- Methotrexate use in rheumatoid Arthritis.
- Examining the exhaled levels of hydrogen peroxide in rheumatoid Arthritis: a pilot study.
- Association of rheumatoid Arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptid...
- Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid Arthritis.
- Early rheumatoid Arthritis: pitfalls in diagnosis and review of recent clinical trials.
- Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid Arthritis and periodontitis.
- Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA.
- Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid Arthritis.
- Anticitrullinated protein antibody (ACPA) in rheumatoid Arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathio...
- State-of-the-art: rheumatoid Arthritis.
- Pharmacotherapy: concepts of pathogenesis and emerging treatments. Challenges in clinical trial design in inflammatory Arthritis.
- Therapeutic options for rheumatoid Arthritis.
- Later comes earlier, nowadays.
- Hydroxychloroquine: a diabetic drug in disguise?
Schools
University Of Nebraska College Of Medicine
University Nebr Med Center
University Of Colorado
Procedures Preformed
- Joint Drainage
- Steroid Injection
- Trigger Point Injection
Conditions Treated
- Arthritis
- Bursitis
- Calcium Pyrophosphate Dihydrate Deposition Disease (CPPD)
- Carpal Tunnel Syndrome
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Colorado -
University of Nebraska Medical Center -
University of Nebraska College of Medicine
Drug Facts
| NPI NUMBER | 1598716839 | |
| NPPES Provider LastName | ODELL | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 681988102 | |
| NPPES Provider State | NE | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 1211.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598716839 |
| Last Name Of The Provider | ODELL |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Manpreet K. Sethi, MB BS |
|
Dr. John A. Hurley, MD |
|
|
Dr. Arthur L. Weaver, MD |
|
|
Dr. Amy C. Cannella, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jay G. Kenik, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Marcus H. Snow, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William R. Palmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Magdalena M. Fiksinski, MD |
|
Dr. Michael G. Feely, MD |
|
|
Dr. Michelene P. Hearth-Holmes, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nada Al-Skaf, MD |
|
|
Dr. Kristin S. Lake, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anhvu N. Nguyen, MD |
|
|
Dr. Melanie K. Rohr, MD |